Can Xeljanz (tofacitinib) treat alopecia areata?
Xeljanz (tofacitinib) is used to treat certain immune-mediated conditions, but the information provided here does not state that Xeljanz 5 mg oral tablets can treat alopecia areata. Because the question asks specifically about alopecia areata and a 5 mg dose, you would need confirmation from an approved indication and dosing guidance for that condition.
Is alopecia areata an on-label use for Xeljanz?
The key point is whether alopecia areata is included as an approved indication for Xeljanz in your country/region. Without that indication listed, you cannot assume it is approved or recommended for alopecia areata treatment, even if it may be studied or used off-label elsewhere.
What dose would be used for alopecia areata (if approved)?
You asked about “Xeljanz 5 mg oral tablet.” Dosing for alopecia areata (if approved) would be based on the product’s label and clinical guidance, which may differ by age, severity, and other health factors. Without labeling information for alopecia areata, the 5 mg dose for this condition cannot be confirmed.
Why patients ask about Xeljanz for hair loss
Alopecia areata is an autoimmune condition that can be driven by inflammatory immune pathways. Medicines that target immune signaling are sometimes researched for hair loss disorders, but that does not automatically mean Xeljanz is approved or safe to use for alopecia areata in the specific dose you mentioned.
Important safety note if you’re considering it for alopecia areata
Even when a drug is used for immune conditions, tofacitinib can carry risks that need clinician screening and monitoring. You should not self-start or change dosing without a prescribing clinician, especially for off-label use.
If you share your country (or a link/photo of the Xeljanz label you’re looking at), I can help you determine whether alopecia areata is an approved indication and what dosing the label specifies.